Clinical Performance of SARS-CoV-2 Molecular Tests-Reference-Cited by-同舟云学术

Clinical Performance of SARS-CoV-2 Molecular Tests

Published:2020-07-23 Issue:8 Volume:58 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Green Daniel A.¹^ORCID,Zucker Jason²,Westblade Lars F.³⁴,Whittier Susan¹,Rennert Hanna³,Velu Priya³,Craney Arryn³,Cushing Melissa³,Liu Dakai⁵,Sobieszczyk Magdalena E.²,Boehme Amelia K.⁶,Sepulveda Jorge L.¹^ORCID

Affiliation:

1. Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, New York, USA

2. Division of Infectious Diseases, Department of Internal Medicine, Columbia University Irving Medical Center, New York, New York, USA

3. Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA

4. Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA

5. Department of Pathology and Clinical Laboratories, NewYork-Presbyterian Queens Hospital, Queens, New York, USA

6. Department of Epidemiology and Neurology, Columbia University Irving Medical Center, New York, New York, USA

Abstract

Molecular testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the gold standard for diagnosis of coronavirus disease 2019 (COVID-19), but the clinical performance of these tests is still poorly understood, particularly with regard to disease course, patient-specific factors, and viral shedding. From 10 March to 1 May 2020, NewYork-Presbyterian laboratories performed 27,377 SARS-CoV-2 molecular assays from 22,338 patients. Repeat testing was performed for 3,432 patients, of which 2,413 had initial negative and 802 had initial positive results.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00995-20

Reference16 articles.

1. A new coronavirus associated with human respiratory disease in China

2. A Novel Coronavirus from Patients with Pneumonia in China, 2019

3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

4. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases;Ai T;Radiology,2020

5. Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-tube protocol for culture-independent spoligotyping of Mycobacterium tuberculosis based on MeltArray;Journal of Clinical Microbiology;2024-01-17

2. Quality of the sample-based RNA determines the real-time RT-PCR results in the laboratory diagnosis of COVID-19;Diagnostic Microbiology and Infectious Disease;2024-01

3. Molecular and serological testing in the setting of a global pandemic;Diagnostic Molecular Pathology;2024

4. Digital Microfluidic Multiplex RT-qPCR for SARS-CoV-2 Detection and Variants Discrimination;Micromachines;2023-08-17

5. Analytical validation of quantitative SARS-CoV-2 subgenomic and viral load laboratory developed tests conducted on the Panther Fusion® (Hologic) with preliminary application to clinical samples;PLOS ONE;2023-06-29